Analysts See $0.22 EPS for Horizon Pharma Public Limited Company (HZNP); Energy Opportunities Capital Management Decreased Superior Energy Svcs Com (SPN) Holding

February 18, 2018 - By Peter Mason

Energy Opportunities Capital Management Llc decreased Superior Energy Svcs Com (SPN) stake by 17.54% reported in 2017Q3 SEC filing. Energy Opportunities Capital Management Llc sold 108,189 shares as Superior Energy Svcs Com (SPN)’s stock declined 27.83%. The Energy Opportunities Capital Management Llc holds 508,754 shares with $5.43 million value, down from 616,943 last quarter. Superior Energy Svcs Com now has $1.36B valuation. The stock decreased 0.34% or $0.03 during the last trading session, reaching $8.91. About 4.35 million shares traded or 25.21% up from the average. Superior Energy Services, Inc. (NYSE:SPN) has declined 25.14% since February 18, 2017 and is downtrending. It has underperformed by 41.84% the S&P500.

Analysts expect Horizon Pharma Public Limited Company (NASDAQ:HZNP) to report $0.22 EPS on February, 26.They anticipate $0.28 EPS change or 56.00% from last quarter’s $0.5 EPS. HZNP’s profit would be $36.05 million giving it 15.78 P/E if the $0.22 EPS is correct. After having $0.26 EPS previously, Horizon Pharma Public Limited Company’s analysts see -15.38% EPS growth. The stock decreased 1.42% or $0.2 during the last trading session, reaching $13.89. About 1.17 million shares traded. Horizon Pharma Public Limited Company (NASDAQ:HZNP) has declined 28.13% since February 18, 2017 and is downtrending. It has underperformed by 44.83% the S&P500.

Investors sentiment increased to 1 in 2017 Q3. Its up 0.08, from 0.92 in 2017Q2. It increased, as 33 investors sold Horizon Pharma Public Limited Company shares while 50 reduced holdings. 28 funds opened positions while 55 raised stakes. 132.29 million shares or 1.03% more from 130.94 million shares in 2017Q2 were reported. Barclays Public Limited Com invested in 1.58M shares or 0.02% of the stock. California Public Employees Retirement System has invested 0.01% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Hutchin Hill Capital Lp holds 0.02% or 41,100 shares. Mackenzie Finance Corp stated it has 0% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP). 83,885 are held by Us Bancorp De. State Of Wisconsin Investment Board holds 127,000 shares. Advisory Svcs Network Ltd Liability Corporation holds 0% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 289 shares. Kopp Inv Advsr Lc reported 1.3% in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Markston Ltd reported 0% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP). Hudson Bay Mgmt Lp holds 0.07% or 225,000 shares. Natl Bank Of Ny Mellon owns 996,609 shares for 0% of their portfolio. Group Inc One Trading L P accumulated 25,901 shares. Tudor Invest Et Al has 25,688 shares. Moreover, Bluemountain Mgmt Ltd Com has 0.01% invested in Horizon Pharma Public Limited Company (NASDAQ:HZNP) for 28,079 shares. Tiaa Cref Inv Mgmt Ltd Limited Liability Company has invested 0% of its portfolio in Horizon Pharma Public Limited Company (NASDAQ:HZNP).

Among 13 analysts covering Horizon Pharma (NASDAQ:HZNP), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. Horizon Pharma had 55 analyst reports since September 9, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) on Thursday, August 17 with “Buy” rating. The company was maintained on Thursday, November 30 by UBS. The rating was maintained by Mizuho on Monday, August 28 with “Hold”. Jefferies maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) rating on Tuesday, August 8. Jefferies has “Buy” rating and $1600 target. Morgan Stanley reinitiated it with “Underweight” rating and $23.0 target in Thursday, December 3 report. Mizuho downgraded the shares of HZNP in report on Friday, December 9 to “Neutral” rating. Jefferies maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) rating on Tuesday, September 12. Jefferies has “Buy” rating and $16.0 target. Jefferies maintained the shares of HZNP in report on Tuesday, November 7 with “Buy” rating. The firm has “Buy” rating by BMO Capital Markets given on Tuesday, September 26. Jefferies maintained Horizon Pharma Public Limited Company (NASDAQ:HZNP) on Friday, October 13 with “Buy” rating.

Horizon Pharma Public Limited Company, a biopharmaceutical company, engages in identifying, developing, acquiring, and commercializing medicines for the treatment of orphan diseases, arthritis, pain, and inflammation and inflammatory diseases in the United States and internationally. The company has market cap of $2.28 billion. The company's marketed medicine portfolio consists of ACTIMMUNE for the treatment of chronic granulomatous disease and malignant osteopetrosis; RAVICTI and BUPHENYL/AMMONAPS to treat urea cycle disorders; PROCYSBI for the treatment of nephropathic cystinosis; QUINSAIR for the treatment of chronic pulmonary infections due to pseudomonas aeruginosa in cystic fibrosis patients; and KRYSTEXXA to treat chronic refractory gout. It currently has negative earnings. The Company’s products also include RAYOS/LODOTRA for the treatment of rheumatoid arthritis, polymyalgia rheumatic, systemic lupus erythematosus, and multiple other indications; DUEXIS to treat signs and symptoms of osteoarthritis and rheumatoid arthritis; MIGERGOT for the treatment of vascular headache; PENNSAID 2% to treat pain of osteoarthritis of the knees; and VIMOVO for the treatment of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

Analysts await Superior Energy Services, Inc. (NYSE:SPN) to report earnings on February, 20. They expect $-0.31 earnings per share, up 58.11% or $0.43 from last year’s $-0.74 per share. After $-0.33 actual earnings per share reported by Superior Energy Services, Inc. for the previous quarter, Wall Street now forecasts -6.06% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Peter Mason

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: